.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Capsules accounted for 76.98% share in July 2026 while Oil held 23.02%, with Capsules up 26.98% year over year but down 10.82% month over month, and Oil up 14.56% year over year and up 6.71% month over month; together these shifts sit alongside a 6.15% decline in average price and a 23.89% brand-level year-over-year sales increase. In Ontario Capsules ranked 12, signaling category presence despite a month-over-month contraction in the lead segment; the mix implies the brand is over-indexed to a single form factor even as Oil expands month over month, suggesting portfolio concentration risk if the Capsules downtick persists.
The divergence between a 10.82% month-over-month decline in Capsules and a 6.71% month-over-month gain in Oil, alongside Capsules’ 26.98% year-over-year growth versus Oil’s 14.56%, implies that near-term demand is tilting toward formats adjacent to Capsules while the legacy growth engine remains Capsules; the implication is that maintaining rank 12 in Capsules will increasingly rely on countering the monthly erosion, possibly via price architecture given the 6.15% average price decrease and the $35.33 current average basket price point. With Capsules at 76.98% mix and Oil at 23.02%, the pathway suggests reallocating activation to Oil to capture the month-over-month momentum while protecting Capsules share, because sustaining July 2026’s 23.89% brand-level year-over-year growth will require balancing the heavier Capsules exposure against Oil’s sequential gains.
Competitive Landscape
C Minor sits at #12 in ON Capsules in July 2026, a 3-rank improvement versus July 2025’s #15, while short-term momentum shows a 1-position gain from #13 in April 2026 and distance from its peak of #9 in September 2024 suggests a ceiling not yet retested; in contrast, Aspire held steady at #1 year over year and Glacial Gold climbed from #4 to #2 as its sales grew 78.1% YoY, whereas Redecan slid from #2 to #3 with a 34.7% YoY sales decline, indicating that C Minor’s gradual rank ascent amid leaders’ divergence points to a pathway for share capture if it can convert mid-table gains into a sustained push back toward single digits.
Notable Products
CBD Fast Acting 50 Max Softgels 30-Pack (1500mg CBD) led the story with a -10.8% month-over-month decline and still held rank 1, while CBD Isolate 100 Max 3000 Oil (30ml) slipped -4.5% at rank 2. In contrast, CBD 50 Max 3000 Oil Drops (60ml) gained 45.1% to rank 3 and CBG:CBD 1:2 Max 2250 Ultra Formula Oil (30ml) rose 35.5% at rank 4, and together three of the top four are Oil SKUs, concentrating mix away from Capsules. The single largest dollar contributor remained the softgels at $22,838 despite the contraction, but the acceleration in Oils at ranks 3 and 4 points to a pivot toward tincture formats driving near-term share of voice. The pattern implies C Minor is shifting from a capsule-led basket toward Oils that are climbing ranks, signaling portfolio momentum concentrated in liquid dose forms.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
